Vident Advisory, LLC Aurinia Pharmaceuticals Inc. Transaction History
Vident Advisory, LLC
- $10.5 Trillion
- Q3 2025
A detailed history of Vident Advisory, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 16,488 shares of AUPH stock, worth $253,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,488
Previous 16,632
0.87%
Holding current value
$253,090
Previous $141 Million
29.33%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AUPH
# of Institutions
270Shares Held
69.4MCall Options Held
984KPut Options Held
574K-
Tang Capital Management LLC San Diego, CA11.3MShares$174 Million5.69% of portfolio
-
Black Rock Inc. New York, NY9.27MShares$142 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.97MShares$60.9 Million2.74% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA3.37MShares$51.8 Million0.03% of portfolio
-
State Street Corp Boston, MA2.69MShares$41.3 Million0.0% of portfolio
About Aurinia Pharmaceuticals Inc.
- Ticker AUPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,892,000
- Market Cap $2.18B
- Description
- Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...